Surgical Sponges Market - Global Forecast to 2029
出版社 | MarketsandMarkets |
出版年月 | 2024年8月 |
ページ数 | 284 |
図表数 | 372 |
価格タイプ | シングルユーザライセンス |
価格 | USD 4,950 |
種別 | 英文調査報告書 |
Report Overview
The global surgical sponges market is valued at an estimated 0.81 billion in 2024 and is projected to reach USD 1.19 billion by 2029, at a CAGR of 7.9% during the forecast period.
世界の外科用スポンジ市場は2024年に8億1,000万米ドルと推定され、予測期間中のCAGRは7.9%で、2029年までに11億9,000万米ドルに達すると予測されています。
The rise in trauma cases and accidents, as well as the development of the healthcare infrastructure, are the primary drivers of the surgical sponges market’s growth. Sterile surgical sponges and other useful surgical supplies are becoming more and more necessary as the frequency of procedures linked to trauma and accidents rises. Therefore, if trauma and accidents become more widespread, there will likely be a greater need for surgical sponges.
“The x-ray detectable sponges segment is projected to witness highest growth rate in the surgical sponges market, by type, during the forecast period”
Based on type, the surgical sponges market is segmented into x-ray detectable sponges, cotton gauze sponges, laparotomy sponges, nonwoven sponges, and other surgical sponges. The ability of x-ray detectable sponges to significantly enhance patient safety by reducing the risk of retained surgical items by identifying leftover surgical items such as surgical sponges during surgical procedures, contributes to their extensive usage and market demand during the forecast period.
“The cotton segment is projected to witness the highest growth rate in the surgical sponges market, by material, during the forecast period.”
Based on material, the surgical sponges market is segmented into cotton, rayon, PVA, and other materials. Cotton is cost-effective, it also have high absorbency, and it is easily available material in most of the regions. Which is making cotton a best choice for hospitals and ambulatory surgical centers, especially in high-volume settings. These factors are contributing to growth of this segment.
“The square & rectangle segment is projected to witness the highest growth rate in the surgical sponges market, in 2023, by shape”
Based on shape, the surgical sponges market is segmented into round & cylindrical, square & rectangle, and other shapes. The square and rectangular shapes make surgical sponges suitable for a range of surgical applications where effective blood and other fluid absorption and coverage are required. Which is contributing to their extensive adoption and market demand during the forecast period.
“The hospitals & ambulatory surgery centers segment is projected to witness the highest growth rate in the surgical sponges market in 2023, by end user”.
Based on end users, the surgical sponges market is segmented hospitals & ambulatory surgery centers, and specialty clinics. The expansion of healthcare infrastructure, particularly in emerging markets, has led to an increase in number of hospitals and ASCs, driving demand for surgical sponges among these end users during the forecasted period.
“The Asia Pacific region is projected to witness highest growth rate in the surgical sponges market during the forecast period”
The global surgical sponges market is segmented into six regions – North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and the GCC Countries. Over the span of the forecast period, the surgical sponges market is expected to grow at the fastest rate in the Asia Pacific region. Over the projected period, the Asia Pacific market is expected to develop at the greatest rate due to factors such government initiatives to raise awareness about illness management and the growing number of hospitals and clinics in China and India.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
- By Designation: C-level – 27%, D-level – 18%, and Others – 55%
- By Region: North America – 35%, Europe – 24%, Asia Pacific – 26%, Latin America – 12%, Middle East & Africa – 2%, and the GCC Countries – 1%
Lists of Companies Profiled in the Report:
Johnson & Johnson Services, Inc. (US), Medline Industries, LP (US), Cardinal Health (US), Integra LifeSciences Corporation (US), Dynarex corporation (US), 3M (US), Medicom (Canada), McKesson Corporation (US), Dukal, LLC (US), DeRoyal Industries, Inc. (US), Owens & Minor Inc. (US), AdvaCare Pharma (US), First aid bandage company (US), AllCare (US), Narang Medical Limited (India), Mölnlycke Health Care AB (Sweden), Aegis Lifesciences (India), SUNDARAM SURGICAL (India), Omni International Corp (US), and Aspen Surgical Products, Inc.(US).
Research Coverage:
In this report, the surgical sponges market has been categorized based on material (cotton, rayon, PVA, and other materials), end user (hospitals & ambulatory surgery centers, and specialty clinics), sterility (sterile surgical sponge, and non-sterile surgical sponge), type (x-ray detectable sponges, cotton gauze sponges, laparotomy sponges, nonwoven sponges, and other surgical sponges), application (general surgery, neurosurgery, laparotomy, dental surgery, ENT surgery, and other applications), shape (round & cylindrical, square & rectangle, and other shapes), and region (North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and the GCC Countries).
Comprehensive information regarding the main drivers, barriers, opportunities, and trends influencing the surgical sponges market’s expansion is included in detail in this study. An exhaustive study of the key players in the surgical sponges market has been done to provide insights into their business profile, products offered, noteworthy strategies, acquisitions and expansions, and other recent activities pertaining to the market. This study examines the competitive landscape of emerging surgical sponge startups.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall surgical sponges market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, trends, opportunities, and restaints.
The report provides insights on the following pointers:
Analysis of key drivers: (Rising number of surgical procedures performed, increasing cases of trauma and accidents, growing gearitric population and increasing prevalence of chronic diseases, and growing healthcare infrastructure), restraints (Risk of retained surgical items (RSIs)), opportunities (Increased adoption of outpatient surgeries, and growth opportunities in emerging economies), and trends (Technological advancements in surgical sponges, and developmentand adoption of biodegradable surgical sponges) influencing the growth of the in surgical sponges market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the surgical sponges market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the surgical sponges market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Johnson & Johnson Services, Inc. (US), Cardinal Health (US), and McKesson Corporation (US) are among others, in the surgical sponges market strategies.
Table of Contents
1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.3 STUDY SCOPE 27
1.3.1 MARKETS COVERED 27
1.3.2 INCLUSIONS & EXCLUSIONS 28
1.3.3 YEARS CONSIDERED 28
1.3.4 CURRENCY CONSIDERED 29
1.4 STAKEHOLDERS 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Key data from secondary sources 32
2.1.2 PRIMARY DATA 32
2.1.2.1 Primary sources 32
2.1.2.2 Key data from primary sources 33
2.1.2.3 Key industry insights 34
2.1.2.4 Breakdown of primary interviews 35
2.2 MARKET SIZE ESTIMATION 35
2.2.1 BOTTOM-UP APPROACH 36
2.2.1.1 Approach 1: Company revenue estimation approach 36
2.2.2 TOP-DOWN APPROACH 38
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 39
2.4 MARKET SHARE ANALYSIS 41
2.5 STUDY ASSUMPTIONS 41
2.5.1 GROWTH RATE ASSUMPTIONS 41
2.6 RESEARCH LIMITATIONS 42
2.6.1 METHODOLOGY-RELATED LIMITATIONS 42
2.6.2 SCOPE-RELATED LIMITATIONS 42
2.7 RISK ASSESSMENT 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 48
4.1 SURGICAL SPONGES MARKET OVERVIEW 48
4.2 ASIA PACIFIC: SURGICAL SPONGES MARKET, BY TYPE AND COUNTRY (2023) 49
4.3 SURGICAL SPONGES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 50
4.4 SURGICAL SPONGES MARKET: REGIONAL MIX (2024–2029) 51
4.5 SURGICAL SPONGES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
5.2.1 DRIVERS 53
5.2.1.1 Rising number of surgical procedures performed 53
5.2.1.2 Increasing trauma and accident cases 54
5.2.1.3 Growing geriatric population and increasing prevalence of chronic diseases 54
5.2.1.4 Healthcare infrastructural development and expansion 55
5.2.2 RESTRAINTS 56
5.2.2.1 Risk of retained surgical items 56
5.2.3 OPPORTUNITIES 57
5.2.3.1 Growth opportunities in emerging economies 57
5.2.3.2 Increased adoption of outpatient surgeries 58
5.2.4 TRENDS 58
5.2.4.1 Development and adoption of biodegradable surgical sponges 58
5.2.4.2 Technological advancements in surgical sponges 58
5.3 PRICING ANALYSIS 59
5.3.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 59
5.3.2 AVERAGE SELLING PRICE TREND, BY REGION 60
5.4 VALUE CHAIN ANALYSIS 60
5.5 SUPPLY CHAIN ANALYSIS 61
5.6 ECOSYSTEM ANALYSIS 62
5.6.1 SURGICAL SPONGES MARKET: ROLE IN ECOSYSTEM 63
5.7 PORTER’S FIVE FORCES ANALYSIS 64
5.7.1 THREAT OF NEW ENTRANTS 65
5.7.2 THREAT OF SUBSTITUTES 65
5.7.3 BARGAINING POWER OF SUPPLIERS 66
5.7.4 BARGAINING POWER OF BUYERS 66
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 66
5.8 KEY STAKEHOLDERS AND BUYING CRITERIA 67
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 67
5.8.2 BUYING CRITERIA 67
5.9 REGULATORY LANDSCAPE 68
5.9.1 NORTH AMERICA 68
5.9.1.1 US 68
5.9.1.2 Canada 69
5.9.2 EUROPE 69
5.9.3 ASIA PACIFIC 69
5.9.3.1 Japan 69
5.9.3.2 China 70
5.9.3.3 India 71
5.9.4 LATIN AMERICA 71
5.9.4.1 Brazil 71
5.9.4.2 Mexico 71
5.9.5 MIDDLE EAST 72
5.9.6 AFRICA 72
5.9.7 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
5.10 TRADE ANALYSIS 74
5.10.1 IMPORT DATA FOR SURGICAL SPONGES 74
5.10.2 EXPORT DATA FOR SURGICAL SPONGES 74
5.11 PATENT ANALYSIS 75
5.11.1 LIST OF MAJOR PATENTS 76
5.12 KEY CONFERENCES AND EVENTS, 2024–2025 76
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 77
5.14 INVESTMENT & FUNDING SCENARIO 78
5.15 IMPACT OF ARTIFICIAL INTELLIGENCE (AI) ON SURGICAL SPONGES MARKET 78
6 SURGICAL SPONGES MARKET, BY TYPE 79
6.1 INTRODUCTION 80
6.2 COTTON GAUZE SPONGES 80
6.2.1 SUPERIOR PROPERTIES OF COTTON GAUZE TO PROPEL GROWTH 80
6.3 X-RAY-DETECTABLE SPONGES 83
6.3.1 ENHANCED PATIENT SAFETY TO BOOST DEMAND 83
6.4 NONWOVEN SPONGES 86
6.4.1 LINT-FREE NATURE OF NONWOVEN SPONGES TO DRIVE GROWTH 86
6.5 LAPAROTOMY SPONGES 89
6.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET 89
6.6 OTHER SURGICAL SPONGES 92
7 SURGICAL SPONGES MARKET, BY MATERIAL 95
7.1 INTRODUCTION 96
7.2 COTTON 96
7.2.1 HIGH ABSORBENCY AND WIDE AVAILABILITY TO BOOST MARKET 96
7.3 RAYON 99
7.3.1 EXCEPTIONAL ABSORBENCY AND SOFTNESS TO PROPEL GROWTH 99
7.4 PVA 101
7.4.1 BIOCOMPATIBILITY OF PVA SPONGES TO DRIVE ADOPTION 101
7.5 OTHER MATERIALS 104
8 SURGICAL SPONGES MARKET, BY SHAPE 107
8.1 INTRODUCTION 108
8.2 SQUARE & RECTANGLE 108
8.2.1 ADAPTABILITY AND WIDE USE TO BOOST MARKET GROWTH 108
8.3 ROUND & CYLINDRICAL 111
8.3.1 PRECISION AND EASE OF MAINTAINING PATIENT SAFETY TO DRIVE MARKET 111
8.4 OTHER SHAPES 114
9 SURGICAL SPONGES MARKET, BY STERILITY 118
9.1 INTRODUCTION 119
9.2 STERILE SURGICAL SPONGES 119
9.2.1 EMPHASIS ON INFECTION CONTROL AND PREVENTION IN HEALTHCARE SETTINGS TO PROMOTE MARKET GROWTH 119
9.3 NON-STERILE SURGICAL SPONGES 122
9.3.1 WIDE USE IN CLEANING WOUNDS AND DRESSING MINOR INJURIES TO PROPEL GROWTH 122
10 SURGICAL SPONGES MARKET, BY APPLICATION 126
10.1 INTRODUCTION 127
10.2 GENERAL SURGERY 127
10.2.1 RISING NUMBER OF HERNIA REPAIR PROCEDURES TO DRIVE MARKET 127
10.3 NEUROSURGERY 130
10.3.1 GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH 130
10.4 LAPAROTOMY 133
10.4.1 RISING NUMBER OF LAPAROTOMY PROCEDURES WORLDWIDE TO DRIVE MARKET 133
10.5 DENTAL SURGERY 136
10.5.1 RISING PREVALENCE OF ORAL DISEASES AND GROWING AWARENESS OF DENTAL CARE TO DRIVE GROWTH 136
10.6 ENT SURGERY 139
10.6.1 INCREASING DISPOSABLE INCOME AND AFFORDABILITY TO BOOST GROWTH 139
10.7 OTHER APPLICATIONS 142
11 SURGICAL SPONGES MARKET, BY END USER 146
11.1 INTRODUCTION 147
11.2 HOSPITALS & AMBULATORY SURGERY CENTERS 147
11.2.1 RISING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS IN HEALTHCARE TO PROMOTE MARKET GROWTH 147
11.3 SPECIALTY CLINICS 150
11.3.1 GROWING NUMBER OF SURGERIES TO DRIVE MARKET 150
12 SURGICAL SPONGES MARKET, BY REGION 154
12.1 INTRODUCTION 155
12.2 NORTH AMERICA 155
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 156
12.2.2 US 160
12.2.2.1 Strong healthcare infrastructure to support market growth 160
12.2.3 CANADA 163
12.2.3.1 Growing geriatric population and increasing volume of surgeries to drive demand 163
12.3 EUROPE 166
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPEAN UNION 167
12.3.2 GERMANY 170
12.3.2.1 Increasing healthcare expenditure and rising per capita disposable income to propel market 170
12.3.3 UK 173
12.3.3.1 Growing volume of cardiovascular surgeries to drive market 173
12.3.4 FRANCE 176
12.3.4.1 Presence of robust healthcare systems to augment market 176
12.3.5 ITALY 179
12.3.5.1 Rising geriatric population and increasing number of chronic diseases to support market 179
12.3.6 SPAIN 182
12.3.6.1 Growing demand for effective surgical outcomes to create major growth opportunities 182
12.3.7 REST OF EUROPE 185
12.4 ASIA PACIFIC 189
12.4.1 MACROECONOMIC OUTLOOK FOR EAST ASIA & PACIFIC 189
12.4.2 CHINA 193
12.4.2.1 Rising number of hospitals and greater public access to modern healthcare to drive market 193
12.4.3 JAPAN 197
12.4.3.1 Rising prevalence of chronic diseases and robust healthcare system to support market 197
12.4.4 INDIA 200
12.4.4.1 Large patient population and developing healthcare sector to drive market 200
12.4.5 REST OF ASIA PACIFIC 203
12.5 LATIN AMERICA 205
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA & CARIBBEAN 206
12.5.2 BRAZIL 209
12.5.2.1 Increasing cases of accidents and traumas to fuel market 209
12.5.3 MEXICO 212
12.5.3.1 Low-cost surgeries and enhanced healthcare infrastructure to aid market 212
12.5.4 REST OF LATIN AMERICA 215
12.6 MIDDLE EAST & AFRICA 218
12.6.1 INCREASED HEALTHCARE INVESTMENTS TO PROPEL MARKET 218
12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & NORTH AFRICA 219
12.7 GCC COUNTRIES 222
12.7.1 ADVANCEMENTS AND INCREASED GOVERNMENT INVESTMENTS IN HEALTHCARE SECTOR TO PROPEL MARKET 222
12.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 223
13 COMPETITIVE LANDSCAPE 227
13.1 OVERVIEW 227
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 227
13.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN SURGICAL SPONGES MARKET 227
13.3 REVENUE ANALYSIS 228
13.4 MARKET SHARE ANALYSIS 229
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 231
13.5.1 STARS 231
13.5.2 EMERGING LEADERS 231
13.5.3 PERVASIVE PLAYERS 231
13.5.4 PARTICIPANTS 231
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 233
13.5.5.1 Company footprint 233
13.5.5.2 Type footprint 234
13.5.5.3 Material footprint 234
13.5.5.4 Shape footprint 235
13.5.5.5 Sterility footprint 235
13.5.5.6 Application footprint 236
13.5.5.7 End-user footprint 236
13.5.5.8 Region footprint 237
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 237
13.6.1 PROGRESSIVE COMPANIES 237
13.6.2 STARTING BLOCKS 237
13.6.3 RESPONSIVE COMPANIES 238
13.6.4 DYNAMIC COMPANIES 238
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 239
13.7 VALUATION & FINANCIAL METRICS 240
13.8 BRAND/PRODUCT COMPARISON 241
13.9 COMPETITIVE SCENARIO 242
13.9.1 DEALS 242
13.9.2 EXPANSIONS 242
13.9.3 OTHER DEVELOPMENTS 242
14 COMPANY PROFILES 243
14.1 KEY PLAYERS 243
14.1.1 JOHNSON & JOHNSON SERVICES, INC. 243
14.1.1.1 Business overview 243
14.1.1.2 Products offered 244
14.1.1.3 MnM view 245
14.1.1.3.1 Right to win 245
14.1.1.3.2 Strategic choices 245
14.1.1.3.3 Weaknesses & competitive threats 245
14.1.2 MCKESSON CORPORATION 246
14.1.2.1 Business overview 246
14.1.2.2 Products offered 247
14.1.2.3 MnM view 247
14.1.2.3.1 Key strengths 247
14.1.2.3.2 Strategic choices 248
14.1.2.3.3 Weaknesses and competitive threats 248
14.1.3 CARDINAL HEALTH 249
14.1.3.1 Business overview 249
14.1.3.2 Products offered 250
14.1.3.3 MnM view 251
14.1.3.3.1 Key strengths 251
14.1.3.3.2 Strategic choices 251
14.1.3.3.3 Weaknesses and competitive threats 251
14.1.4 3M 252
14.1.4.1 Business overview 252
14.1.4.2 Products offered 253
14.1.4.3 Recent developments 254
14.1.4.3.1 Other developments 254
14.1.4.4 MnM view 254
14.1.4.4.1 Key strengths 254
14.1.4.4.2 Strategic choices 254
14.1.4.4.3 Weaknesses and competitive threats 254
14.1.5 INTEGRA LIFESCIENCES CORPORATION 255
14.1.5.1 Business overview 255
14.1.5.2 Products offered 256
14.1.5.3 Recent developments 257
14.1.5.3.1 Deals 257
14.1.6 MEDICOM 258
14.1.6.1 Business overview 258
14.1.6.2 Products offered 258
14.1.7 MEDLINE INDUSTRIES, LP. 260
14.1.7.1 Business overview 260
14.1.7.2 Product offered 260
14.1.7.3 Recent developments 261
14.1.7.3.1 Expansions 261
14.1.8 DEROYAL INDUSTRIES, INC. 262
14.1.8.1 Business overview 262
14.1.8.2 Product offered 262
14.1.9 DUKAL LLC 263
14.1.9.1 Business overview 263
14.1.9.2 Product offered 263
14.1.10 DYNAREX CORPORATION 265
14.1.10.1 Business overview 265
14.1.10.2 Product offered 265
14.2 OTHER PLAYERS 266
14.2.1 OWENS & MINOR 266
14.2.2 ADVACARE PHARMA 267
14.2.3 FIRST AID BANDAGE COMPANY 268
14.2.4 MÖLNLYCKE HEALTH CARE AB 269
14.2.5 ALLCARE 270
14.2.6 NARANG MEDICAL LIMITED 271
14.2.7 AEGIS LIFESCIENCES 272
14.2.8 SUNDARAM SURGICAL 273
14.2.9 ASPEN SURGICAL PRODUCTS 274
14.2.10 OMNI INTERNATIONAL CORP 274
15 APPENDIX 275
15.1 DISCUSSION GUIDE 275
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 280
15.3 CUSTOMIZATION OPTIONS 282
15.4 RELATED REPORTS 282
15.5 AUTHOR DETAILS 283
LIST OF TABLES
TABLE 1 NUMBER OF SURGERIES PERFORMED, BY COUNTRY AND TYPE, 2021 VS. 2022 53
TABLE 2 INDIA: TOTAL NUMBER OF ACCIDENTS, FATALITIES, AND INJURIES, 2018 TO 2022 54
TABLE 3 TOTAL NUMBER OF CORONARY ARTERY BYPASS GRAFT PROCEDURES,
2021 VS. 2022 55
TABLE 4 COST OF SURGICAL PROCEDURES: US VS. INDIA (USD) 57
TABLE 5 AVERAGE SELLING PRICE TREND OF KEY SURGICAL SPONGE PRODUCTS,
2021–2023 59
TABLE 6 AVERAGE SELLING PRICE TREND OF SURGICAL SPONGES, BY REGION,
2021–2023 60
TABLE 7 SURGICAL SPONGES MARKET: PORTER’S FIVE FORCES ANALYSIS 64
TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 67
TABLE 9 KEY BUYING CRITERIA FOR SURGICAL SPONGE END USERS 68
TABLE 10 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 69
TABLE 11 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN 70
TABLE 12 NMPA MEDICAL DEVICES CLASSIFICATION 70
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 72
TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 73
TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 73
TABLE 16 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 73
TABLE 17 IMPORT DATA FOR SURGICAL SPONGES (HS CODE 901890), BY COUNTRY,
2018–2023 (USD MILLION) 74
TABLE 18 EXPORT DATA FOR SURGICAL SPONGES (HS CODE 901890), BY COUNTRY,
2018–2023 (USD MILLION) 74
TABLE 19 SURGICAL SPONGES MARKET: DETAILED LIST OF CONFERENCES
AND EVENTS, 2024–2025 76
TABLE 20 SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 80
TABLE 21 COTTON GAUZE SPONGES: PRODUCTS OFFERED, BY COMPANY 81
TABLE 22 COTTON GAUZE SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION) 81
TABLE 23 NORTH AMERICA: COTTON GAUZE SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 81
TABLE 24 EUROPE: COTTON GAUZE SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 82
TABLE 25 ASIA PACIFIC: COTTON GAUZE SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 82
TABLE 26 LATIN AMERICA: COTTON GAUZE SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 83
TABLE 27 X-RAY-DETECTABLE SPONGES: PRODUCTS OFFERED, BY COMPANY 83
TABLE 28 X-RAY-DETECTABLE SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION) 84
TABLE 29 NORTH AMERICA: X-RAY-DETECTABLE SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 84
TABLE 30 EUROPE: X-RAY-DETECTABLE SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 85
TABLE 31 ASIA PACIFIC: X-RAY-DETECTABLE SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 85
TABLE 32 LATIN AMERICA: X-RAY-DETECTABLE SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 86
TABLE 33 NONWOVEN SPONGES: PRODUCTS OFFERED, BY COMPANY 86
TABLE 34 NONWOVEN SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION) 87
TABLE 35 NORTH AMERICA: NONWOVEN SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 87
TABLE 36 EUROPE: NONWOVEN SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 88
TABLE 37 ASIA PACIFIC: NONWOVEN SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 88
TABLE 38 LATIN AMERICA: NONWOVEN SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 89
TABLE 39 LAPAROTOMY SPONGES: PRODUCTS OFFERED, BY COMPANY 89
TABLE 40 LAPAROTOMY SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION) 90
TABLE 41 NORTH AMERICA: LAPAROTOMY SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 90
TABLE 42 EUROPE: LAPAROTOMY SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 91
TABLE 43 ASIA PACIFIC: LAPAROTOMY SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 91
TABLE 44 LATIN AMERICA: LAPAROTOMY SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 92
TABLE 45 OTHER SURGICAL SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION) 92
TABLE 46 NORTH AMERICA: OTHER SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 93
TABLE 47 EUROPE: OTHER SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 93
TABLE 48 ASIA PACIFIC: OTHER SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 94
TABLE 49 LATIN AMERICA: OTHER SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 94
TABLE 50 SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 96
TABLE 51 COTTON SURGICAL SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION) 97
TABLE 52 NORTH AMERICA: COTTON SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 97
TABLE 53 EUROPE: COTTON SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 98
TABLE 54 ASIA PACIFIC: COTTON SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 98
TABLE 55 LATIN AMERICA: COTTON SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 99
TABLE 56 RAYON SURGICAL SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION) 99
TABLE 57 NORTH AMERICA: RAYON SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 100
TABLE 58 EUROPE: RAYON SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 100
TABLE 59 ASIA PACIFIC: RAYON SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 101
TABLE 60 LATIN AMERICA: RAYON SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 101
TABLE 61 PVA SURGICAL SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION) 102
TABLE 62 NORTH AMERICA: PVA SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 102
TABLE 63 EUROPE: PVA SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 103
TABLE 64 ASIA PACIFIC: PVA SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 103
TABLE 65 LATIN AMERICA: PVA SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 104
TABLE 66 OTHER SURGICAL SPONGE MATERIALS MARKET, BY REGION,
2022–2029 (USD MILLION) 104
TABLE 67 NORTH AMERICA: OTHER SURGICAL SPONGE MATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 105
TABLE 68 EUROPE: OTHER SURGICAL SPONGE MATERIALS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 105
TABLE 69 ASIA PACIFIC: OTHER SURGICAL SPONGE MATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 106
TABLE 70 LATIN AMERICA: OTHER SURGICAL SPONGE MATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 106
TABLE 71 SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 108
TABLE 72 SQUARE & RECTANGLE SURGICAL SPONGES: PRODUCTS OFFERED, BY COMPANY 109
TABLE 73 SQUARE & RECTANGULAR SURGICAL SPONGES MARKET, BY REGION,
2022–2029 (USD MILLION) 109
TABLE 74 NORTH AMERICA: SQUARE & RECTANGULAR SURGICAL SPONGES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 75 EUROPE: SQUARE & RECTANGULAR SURGICAL SPONGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 76 ASIA PACIFIC: SQUARE & RECTANGULAR SURGICAL SPONGES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 77 LATIN AMERICA: SQUARE & RECTANGULAR SURGICAL SPONGES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 78 ROUND & CYLINDRICAL SURGICAL SPONGES: PRODUCTS OFFERED, BY COMPANY 112
TABLE 79 ROUND & CYLINDRICAL SURGICAL SPONGES MARKET, BY REGION,
2022–2029 (USD MILLION) 112
TABLE 80 NORTH AMERICA: ROUND & CYLINDRICAL SURGICAL SPONGES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 112
TABLE 81 EUROPE: ROUND & CYLINDRICAL SURGICAL SPONGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 82 ASIA PACIFIC: ROUND & CYLINDRICAL SURGICAL SPONGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 83 LATIN AMERICA: ROUND & CYLINDRICAL SURGICAL SPONGES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 84 SURGICAL SPONGES MARKET FOR OTHER SHAPES, BY REGION,
2022–2029 (USD MILLION) 115
TABLE 85 NORTH AMERICA: SURGICAL SPONGES MARKET FOR OTHER SHAPES,
BY COUNTRY, 2022–2029 (USD MILLION) 115
TABLE 86 EUROPE: SURGICAL SPONGES MARKET FOR OTHER SHAPES, BY COUNTRY,
2022–2029 (USD MILLION) 116
TABLE 87 ASIA PACIFIC: SURGICAL SPONGES MARKET FOR OTHER SHAPES, BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 88 LATIN AMERICA: SURGICAL SPONGES MARKET FOR OTHER SHAPES, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 89 SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 119
TABLE 90 STERILE SURGICAL SPONGES: PRODUCTS OFFERED, BY COMPANY 120
TABLE 91 STERILE SURGICAL SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION) 120
TABLE 92 NORTH AMERICA: STERILE SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 121
TABLE 93 EUROPE: STERILE SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 121
TABLE 94 ASIA PACIFIC: STERILE SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 122
TABLE 95 LATIN AMERICA: STERILE SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 122
TABLE 96 NON-STERILE SURGICAL SPONGES: PRODUCTS OFFERED, BY COMPANY 123
TABLE 97 NON-STERILE SURGICAL SPONGES MARKET, BY REGION,
2022–2029 (USD MILLION) 123
TABLE 98 NORTH AMERICA: NON-STERILE SURGICAL SPONGES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 99 EUROPE: NON-STERILE SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 124
TABLE 100 ASIA PACIFIC: NON-STERILE SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 125
TABLE 101 LATIN AMERICA: NON-STERILE SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 125
TABLE 102 SURGICAL SPONGES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 127
TABLE 103 TOTAL NUMBER OF INGUINAL HERNIA REPAIR PROCEDURES, 2021 VS. 2022 128
TABLE 104 SURGICAL SPONGES MARKET FOR GENERAL SURGERY, BY REGION,
2022–2029 (USD MILLION) 128
TABLE 105 NORTH AMERICA: SURGICAL SPONGES MARKET FOR GENERAL SURGERY,
BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 106 EUROPE: SURGICAL SPONGES MARKET FOR GENERAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 107 ASIA PACIFIC: SURGICAL SPONGES MARKET FOR GENERAL SURGERY,
BY COUNTRY, 2022–2029 (USD MILLION) 130
TABLE 108 LATIN AMERICA: SURGICAL SPONGES MARKET FOR GENERAL SURGERY,
BY COUNTRY, 2022–2029 (USD MILLION) 130
TABLE 109 SURGICAL SPONGES MARKET FOR NEUROSURGERY, BY REGION,
2022–2029 (USD MILLION) 131
TABLE 110 NORTH AMERICA: SURGICAL SPONGES MARKET FOR NEUROSURGERY,
BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 111 EUROPE: SURGICAL SPONGES MARKET FOR NEUROSURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 112 ASIA PACIFIC: SURGICAL SPONGES MARKET FOR NEUROSURGERY,
BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 113 LATIN AMERICA: SURGICAL SPONGES MARKET FOR NEUROSURGERY,
BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 114 SURGICAL SPONGES MARKET FOR LAPAROTOMY, BY REGION,
2022–2029 (USD MILLION) 134
TABLE 115 NORTH AMERICA: SURGICAL SPONGES MARKET FOR LAPAROTOMY, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 116 EUROPE: SURGICAL SPONGES MARKET FOR LAPAROTOMY, BY COUNTRY,
2022–2029 (USD MILLION) 135
TABLE 117 ASIA PACIFIC: SURGICAL SPONGES MARKET FOR LAPAROTOMY, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 118 LATIN AMERICA: SURGICAL SPONGES MARKET FOR LAPAROTOMY, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 119 SURGICAL SPONGES MARKET FOR DENTAL SURGERY, BY REGION,
2022–2029 (USD MILLION) 137
TABLE 120 NORTH AMERICA: SURGICAL SPONGES MARKET FOR DENTAL SURGERY,
BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 121 EUROPE: SURGICAL SPONGES MARKET FOR DENTAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 122 ASIA PACIFIC: SURGICAL SPONGES MARKET FOR DENTAL SURGERY,
BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 123 LATIN AMERICA: SURGICAL SPONGES MARKET FOR DENTAL SURGERY,
BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 124 SURGICAL SPONGES MARKET FOR ENT SURGERY, BY REGION,
2022–2029 (USD MILLION) 140
TABLE 125 NORTH AMERICA: SURGICAL SPONGES MARKET FOR ENT SURGERY,
BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 126 EUROPE: SURGICAL SPONGES MARKET FOR ENT SURGERY, BY COUNTRY,
2022–2029 (USD MILLION) 141
TABLE 127 ASIA PACIFIC: SURGICAL SPONGES MARKET FOR ENT SURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 128 LATIN AMERICA: SURGICAL SPONGES MARKET FOR ENT SURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 129 SURGICAL SPONGES MARKET FOR OTHER APPLICATIONS, BY REGION,
2022–2029 (USD MILLION) 143
TABLE 130 NORTH AMERICA: SURGICAL SPONGES MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 131 EUROPE: SURGICAL SPONGES MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 132 ASIA PACIFIC: SURGICAL SPONGES MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 133 LATIN AMERICA: SURGICAL SPONGES MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 134 SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 147
TABLE 135 SURGICAL SPONGES MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY REGION, 2022–2029 (USD MILLION) 148
TABLE 136 NORTH AMERICA: SURGICAL SPONGES MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 137 EUROPE: SURGICAL SPONGES MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 138 ASIA PACIFIC: SURGICAL SPONGES MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 139 LATIN AMERICA: SURGICAL SPONGES MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 140 SURGICAL SPONGES MARKET FOR SPECIALTY CLINICS, BY REGION,
2022–2029 (USD MILLION) 151
TABLE 141 NORTH AMERICA: SURGICAL SPONGES MARKET FOR SPECIALTY CLINICS,
BY COUNTRY, 2022–2029 (USD MILLION) 151
TABLE 142 EUROPE: SURGICAL SPONGES MARKET FOR SPECIALTY CLINICS,
BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 143 ASIA PACIFIC: SURGICAL SPONGES MARKET FOR SPECIALTY CLINICS,
BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 144 LATIN AMERICA: SURGICAL SPONGES MARKET FOR SPECIALTY CLINICS,
BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 145 SURGICAL SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION) 155
TABLE 146 NORTH AMERICA: MACROECONOMIC OUTLOOK 156
TABLE 147 NORTH AMERICA: SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 158
TABLE 148 NORTH AMERICA: SURGICAL SPONGES MARKET, BY TYPE,
2022–2029 (USD MILLION) 158
TABLE 149 NORTH AMERICA: SURGICAL SPONGES MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 158
TABLE 150 NORTH AMERICA: SURGICAL SPONGES MARKET, BY SHAPE,
2022–2029 (USD MILLION) 159
TABLE 151 NORTH AMERICA: SURGICAL SPONGES MARKET, BY STERILITY,
2022–2029 (USD MILLION) 159
TABLE 152 NORTH AMERICA: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 159
TABLE 153 NORTH AMERICA: SURGICAL SPONGES MARKET, BY END USER,
2022–2029 (USD MILLION) 160
TABLE 154 US: NUMBER OF SURGERIES PERFORMED, 2022–2029 (USD MILLION) 161
TABLE 155 US: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 161
TABLE 156 US: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 161
TABLE 157 US: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 162
TABLE 158 US: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 162
TABLE 159 US: SURGICAL SPONGES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 162
TABLE 160 US: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 163
TABLE 161 CANADA: SURGICAL PROCEDURES PERFORMED, 2021 VS. 2022 164
TABLE 162 CANADA: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 164
TABLE 163 CANADA: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 164
TABLE 164 CANADA: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 165
TABLE 165 CANADA: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 165
TABLE 166 CANADA: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 165
TABLE 167 CANADA: SURGICAL SPONGES MARKET, BY END USER,
2022–2029 (USD MILLION) 166
TABLE 168 EUROPEAN UNION: MACROECONOMIC OUTLOOK 167
TABLE 169 EUROPE: SURGICAL SPONGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 170 EUROPE: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 168
TABLE 171 EUROPE: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 168
TABLE 172 EUROPE: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 168
TABLE 173 EUROPE: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 169
TABLE 174 EUROPE: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 169
TABLE 175 EUROPE: SURGICAL SPONGES MARKET, BY END USER,
2022–2029 (USD MILLION) 169
TABLE 176 GERMANY: SURGICAL PROCEDURES PERFORMED, 2021 VS. 2022 170
TABLE 177 GERMANY: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 171
TABLE 178 GERMANY: SURGICAL SPONGES MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 171
TABLE 179 GERMANY: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 171
TABLE 180 GERMANY: SURGICAL SPONGES MARKET, BY STERILITY,
2022–2029 (USD MILLION) 172
TABLE 181 GERMANY: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 172
TABLE 182 GERMANY: SURGICAL SPONGES MARKET, BY END USER,
2022–2029 (USD MILLION) 172
TABLE 183 UK: SURGICAL PROCEDURES PERFORMED, 2021 VS. 2022 173
TABLE 184 UK: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 185 UK: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 174
TABLE 186 UK: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 174
TABLE 187 UK: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 175
TABLE 188 UK: SURGICAL SPONGES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 175
TABLE 189 UK: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 175
TABLE 190 FRANCE: SURGICAL PROCEDURES PERFORMED, 2021 VS. 2022 176
TABLE 191 FRANCE: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 177
TABLE 192 FRANCE: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 177
TABLE 193 FRANCE: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 177
TABLE 194 FRANCE: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 178
TABLE 195 FRANCE: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 178
TABLE 196 FRANCE: SURGICAL SPONGES MARKET, BY END USER,
2022–2029 (USD MILLION) 178
TABLE 197 ITALY: SURGICAL PROCEDURES PERFORMED, 2021 VS. 2022 179
TABLE 198 ITALY: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 180
TABLE 199 ITALY: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 180
TABLE 200 ITALY: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 180
TABLE 201 ITALY: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 181
TABLE 202 ITALY: SURGICAL SPONGES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 181
TABLE 203 ITALY: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 181
TABLE 204 SPAIN: SURGICAL PROCEDURES PERFORMED, 2021 VS. 2022 182
TABLE 205 SPAIN: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 183
TABLE 206 SPAIN: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 183
TABLE 207 SPAIN: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 183
TABLE 208 SPAIN: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 184
TABLE 209 SPAIN: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 184
TABLE 210 SPAIN: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 184
TABLE 211 REST OF EUROPE: SURGICAL OPERATIONS AND PROCEDURES PERFORMED IN HOSPITALS, 2021 (PER 100,000 INHABITANTS) 186
TABLE 212 REST OF EUROPE: SURGICAL SPONGES MARKET, BY TYPE,
2022–2029 (USD MILLION) 186
TABLE 213 REST OF EUROPE: SURGICAL SPONGES MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 187
TABLE 214 REST OF EUROPE: SURGICAL SPONGES MARKET, BY SHAPE,
2022–2029 (USD MILLION) 187
TABLE 215 REST OF EUROPE: SURGICAL SPONGES MARKET, BY STERILITY,
2022–2029 (USD MILLION) 187
TABLE 216 REST OF EUROPE: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 188
TABLE 217 REST OF EUROPE: SURGICAL SPONGES MARKET, BY END USER,
2022–2029 (USD MILLION) 188
TABLE 218 EAST ASIA & PACIFIC: MACROECONOMIC OUTLOOK 189
TABLE 219 ASIA PACIFIC: SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 191
TABLE 220 ASIA PACIFIC: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 221 ASIA PACIFIC: SURGICAL SPONGES MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 192
TABLE 222 ASIA PACIFIC: SURGICAL SPONGES MARKET, BY SHAPE,
2022–2029 (USD MILLION) 192
TABLE 223 ASIA PACIFIC: SURGICAL SPONGES MARKET, BY STERILITY,
2022–2029 (USD MILLION) 192
TABLE 224 ASIA PACIFIC: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 193
TABLE 225 ASIA PACIFIC: SURGICAL SPONGES MARKET, BY END USER,
2022–2029 (USD MILLION) 193
TABLE 226 CHINA: CANCER INCIDENCE, MORTALITY, AND PREVALENCE, BY TYPE, 2022 194
TABLE 227 CHINA: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 228 CHINA: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 195
TABLE 229 CHINA: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 195
TABLE 230 CHINA: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 196
TABLE 231 CHINA: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 196
TABLE 232 CHINA: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 196
TABLE 233 JAPAN: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 234 JAPAN: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 198
TABLE 235 JAPAN: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 198
TABLE 236 JAPAN: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 199
TABLE 237 JAPAN: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 199
TABLE 238 JAPAN: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 199
TABLE 239 INDIA: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 240 INDIA: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 201
TABLE 241 INDIA: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 201
TABLE 242 INDIA: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 202
TABLE 243 INDIA: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 202
TABLE 244 INDIA: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 202
TABLE 245 REST OF ASIA PACIFIC: SURGICAL SPONGES MARKET, BY TYPE,
2022–2029 (USD MILLION) 203
TABLE 246 REST OF ASIA PACIFIC: SURGICAL SPONGES MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 204
TABLE 247 REST OF ASIA PACIFIC: SURGICAL SPONGES MARKET, BY SHAPE,
2022–2029 (USD MILLION) 204
TABLE 248 REST OF ASIA PACIFIC: SURGICAL SPONGES MARKET, BY STERILITY,
2022–2029 (USD MILLION) 204
TABLE 249 REST OF ASIA PACIFIC: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 205
TABLE 250 REST OF ASIA PACIFIC: SURGICAL SPONGES MARKET, BY END USER,
2022–2029 (USD MILLION) 205
TABLE 251 LATIN AMERICA & CARIBBEAN: MACROECONOMIC OUTLOOK 206
TABLE 252 LATIN AMERICA: SURGICAL SPONGES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 206
TABLE 253 LATIN AMERICA: SURGICAL SPONGES MARKET, BY TYPE,
2022–2029 (USD MILLION) 207
TABLE 254 LATIN AMERICA: SURGICAL SPONGES MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 207
TABLE 255 LATIN AMERICA: SURGICAL SPONGES MARKET, BY SHAPE,
2022–2029 (USD MILLION) 208
TABLE 256 LATIN AMERICA: SURGICAL SPONGES MARKET, BY STERILITY,
2022–2029 (USD MILLION) 208
TABLE 257 LATIN AMERICA: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 208
TABLE 258 LATIN AMERICA: SURGICAL SPONGES MARKET, BY END USER,
2022–2029 (USD MILLION) 209
TABLE 259 BRAZIL: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 210
TABLE 260 BRAZIL: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 210
TABLE 261 BRAZIL: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 210
TABLE 262 BRAZIL: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 211
TABLE 263 BRAZIL: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 211
TABLE 264 BRAZIL: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 211
TABLE 265 MEXICO: SURGICAL PROCEDURES PERFORMED, 2021 VS. 2022 212
TABLE 266 MEXICO: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 213
TABLE 267 MEXICO: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 213
TABLE 268 MEXICO: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 213
TABLE 269 MEXICO: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 214
TABLE 270 MEXICO: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 214
TABLE 271 MEXICO: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 214
TABLE 272 REST OF LATIN AMERICA: SURGICAL SPONGES MARKET, BY TYPE,
2022–2029 (USD MILLION) 216
TABLE 273 REST OF LATIN AMERICA: SURGICAL SPONGES MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 216
TABLE 274 REST OF LATIN AMERICA: SURGICAL SPONGES MARKET, BY SHAPE,
2022–2029 (USD MILLION) 217
TABLE 275 REST OF LATIN AMERICA: SURGICAL SPONGES MARKET, BY STERILITY,
2022–2029 (USD MILLION) 217
TABLE 276 REST OF LATIN AMERICA: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 218
TABLE 277 REST OF LATIN AMERICA: SURGICAL SPONGES MARKET, BY END USER,
2022–2029 (USD MILLION) 218
TABLE 278 MIDDLE EAST & NORTH AFRICA: MACROECONOMIC OUTLOOK 219
TABLE 279 MIDDLE EAST & AFRICA: SURGICAL SPONGES MARKET, BY TYPE,
2022–2029 (USD MILLION) 220
TABLE 280 MIDDLE EAST & AFRICA: SURGICAL SPONGES MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 220
TABLE 281 MIDDLE EAST & AFRICA: SURGICAL SPONGES MARKET, BY SHAPE,
2022–2029 (USD MILLION) 221
TABLE 282 MIDDLE EAST & AFRICA: SURGICAL SPONGES MARKET, BY STERILITY,
2022–2029 (USD MILLION) 221
TABLE 283 MIDDLE EAST & AFRICA: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 222
TABLE 284 MIDDLE EAST & AFRICA: SURGICAL SPONGES MARKET, BY END USER,
2022–2029 (USD MILLION) 222
TABLE 285 GCC COUNTRIES: MACROECONOMIC OUTLOOK 223
TABLE 286 GCC COUNTRIES: SURGICAL SPONGES MARKET, BY TYPE,
2022–2029 (USD MILLION) 224
TABLE 287 GCC COUNTRIES: SURGICAL SPONGES MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 224
TABLE 288 GCC COUNTRIES: SURGICAL SPONGES MARKET, BY SHAPE,
2022–2029 (USD MILLION) 225
TABLE 289 GCC COUNTRIES: SURGICAL SPONGES MARKET, BY STERILITY,
2022–2029 (USD MILLION) 225
TABLE 290 GCC COUNTRIES: SURGICAL SPONGES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 225
TABLE 291 GCC COUNTRIES: SURGICAL SPONGES MARKET, BY END USER,
2022–2029 (USD MILLION) 226
TABLE 292 OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS 227
TABLE 293 SURGICAL SPONGES MARKET: DEGREE OF COMPETITION 230
TABLE 294 SURGICAL SPONGES MARKET: TYPE FOOTPRINT 234
TABLE 295 SURGICAL SPONGES MARKET: MATERIAL FOOTPRINT 234
TABLE 296 SURGICAL SPONGES MARKET: SHAPE FOOTPRINT 235
TABLE 297 SURGICAL SPONGES MARKET: STERILITY FOOTPRINT 235
TABLE 298 SURGICAL SPONGES MARKET: APPLICATION FOOTPRINT 236
TABLE 299 SURGICAL SPONGES MARKET: END-USER FOOTPRINT 236
TABLE 300 SURGICAL SPONGES MARKET: REGION FOOTPRINT 237
TABLE 301 SURGICAL SPONGES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 239
TABLE 302 SURGICAL SPONGES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 239
TABLE 303 SURGICAL SPONGES MARKET: DEALS, JANUARY 2021–JUNE 2024 242
TABLE 304 SURGICAL SPONGES MARKET: EXPANSIONS, JANUARY 2021–JUNE 2024 242
TABLE 305 SURGICAL SPONGES MARKET: OTHER DEVELOPMENTS,
JANUARY 2021–JUNE 2024 242
TABLE 306 JOHNSON & JOHNSON SERVICES, INC.: BUSINESS OVERVIEW 243
TABLE 307 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED 244
TABLE 308 MCKESSON CORPORATION: BUSINESS OVERVIEW 246
TABLE 309 MCKESSON CORPORATION: PRODUCTS OFFERED 247
TABLE 310 CARDINAL HEALTH: BUSINESS OVERVIEW 249
TABLE 311 CARDINAL HEALTH: PRODUCTS OFFERED 250
TABLE 312 3M: COMPANY OVERVIEW 252
TABLE 313 3M: PRODUCTS OFFERED 253
TABLE 314 3M: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024 254
TABLE 315 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 255
TABLE 316 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED 256
TABLE 317 INTEGRA LIFESCIENCES CORPORATION: DEALS, JANUARY 2021–JUNE 2024 257
TABLE 318 MEDICOM: COMPANY OVERVIEW 258
TABLE 319 MEDICOM: PRODUCTS OFFERED 258
TABLE 320 MEDLINE INDUSTRIES, LP.: BUSINESS OVERVIEW 260
TABLE 321 MEDLINE INDUSTRIES, LP.: PRODUCT OFFERED 260
TABLE 322 MEDLINE INDUSTRIES, LP.: EXPANSIONS, JANUARY 2021–JUNE 2024 261
TABLE 323 DEROYAL INDUSTRIES, INC.: BUSINESS OVERVIEW 262
TABLE 324 DEROYAL INDUSTRIES, INC.: PRODUCT OFFERED 262
TABLE 325 DUKAL LLC: BUSINESS OVERVIEW 263
TABLE 326 DUKAL LLC: PRODUCT OFFERED 263
TABLE 327 DYNAREX CORPORATION: BUSINESS OVERVIEW 265
TABLE 328 DYNAREX CORPORATION: PRODUCT OFFERED 265
LIST OF FIGURES
FIGURE 1 SURGICAL SPONGES MARKET: RESEARCH DESIGN 30
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 35
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 35
FIGURE 4 SURGICAL SPONGES MARKET: REVENUE SHARE ANALYSIS 36
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38
FIGURE 6 SURGICAL SPONGES MARKET: TOP-DOWN APPROACH 39
FIGURE 7 DATA TRIANGULATION METHODOLOGY 40
FIGURE 8 SURGICAL SPONGES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 43
FIGURE 9 SURGICAL SPONGES MARKET, BY MATERIAL, 2024 VS. 2029 (USD MILLION) 44
FIGURE 10 SURGICAL SPONGES MARKET, BY SHAPE, 2024 VS. 2029 (USD MILLION) 44
FIGURE 11 SURGICAL SPONGES MARKET, BY STERILITY, 2024 VS. 2029 (USD MILLION) 45
FIGURE 12 SURGICAL SPONGES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 46
FIGURE 13 SURGICAL SPONGES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 46
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF SURGICAL SPONGES MARKET 47
FIGURE 15 RISING VOLUME OF SURGERIES AND INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH 48
FIGURE 16 COTTON GAUZE SPONGES ACCOUNTED FOR LARGEST SHARE IN 2023 49
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH IN SURGICAL SPONGES MARKET FROM 2024 TO 2029 50
FIGURE 18 APAC TO WITNESS HIGHEST GROWTH OVER FORECAST PERIOD 51
FIGURE 19 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING
FORECAST PERIOD 51
FIGURE 20 SURGICAL SPONGES MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND TRENDS 52
FIGURE 21 VALUE CHAIN ANALYSIS OF SURGICAL SPONGES MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 61
FIGURE 22 SURGICAL SPONGES MARKET: SUPPLY CHAIN ANALYSIS 62
FIGURE 23 SURGICAL SPONGES MARKET: ECOSYSTEM 63
FIGURE 24 SURGICAL SPONGES MARKET: KEY STAKEHOLDERS IN ECOSYSTEM 64
FIGURE 25 SURGICAL SPONGES MARKET: PORTER’S FIVE FORCES ANALYSIS 65
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 67
FIGURE 27 KEY BUYING CRITERIA FOR SURGICAL SPONGE END USERS 67
FIGURE 28 PATENT ANALYSIS FOR SURGICAL SPONGES (JANUARY 2013–DECEMBER 2023) 75
FIGURE 29 REVENUE SHIFT IN SURGICAL SPONGES MARKET 77
FIGURE 30 NORTH AMERICA: SURGICAL SPONGES MARKET SNAPSHOT 157
FIGURE 31 ASIA PACIFIC: SURGICAL SPONGES MARKET SNAPSHOT 190
FIGURE 32 REVENUE ANALYSIS OF TOP PLAYERS IN SURGICAL SPONGES MARKET 229
FIGURE 33 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SURGICAL SPONGES
MARKET (2023) 229
FIGURE 34 SURGICAL SPONGES MARKET: COMPANY EVALUATION
MATRIX (KEY PLAYERS), 2023 232
FIGURE 35 SURGICAL SPONGES MARKET: COMPANY FOOTPRINT 233
FIGURE 36 SURGICAL SPONGES MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2023 238
FIGURE 37 EV/EBITDA OF KEY VENDORS 240
FIGURE 38 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 240
FIGURE 39 SURGICAL SPONGES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 241
FIGURE 40 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2023) 244
FIGURE 41 MCKESSON CORPORATION: COMPANY SNAPSHOT (2024) 246
FIGURE 42 CARDINAL HEALTH: COMPANY SNAPSHOT (2023) 250
FIGURE 43 3M: COMPANY SNAPSHOT (2023) 253
FIGURE 44 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023) 256
MarketsandMarkets(マーケッツアンドマーケッツ)は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間~12時間以内(営業日基準)にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
シングルユーザ | コーポレート |
USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内(関連会社除く)5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100%持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内(営業日基準)
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 栄養補助食品用包装市場 – 2030年までの世界予測 2025-04-07
- 産業用ボイラー市場 – 2030年までの世界予測 2025-04-04
- オープンギア用潤滑油市場 – 2030年までの世界予測 2025-04-04
- 建設重機市場 – 2030年までの世界予測 2025-04-03
- 従来の創傷ケア市場 – 2030年までの世界予測 2025-04-02